Akèy › Trombositemi Esansyèl › Massachusetts › Boston
Etid klinik pou Trombositemi Esansyèl nan Boston, MA
4 etid pou Trombositemi Esansyèl ap chèche patisipan nan sit nan ak bò kote Boston (nan yon distans apeprè 30 mil). Louvri yon etid pou wè ki moun ki ka patisipe ak kijan pou kontakte ekip etid la.
Tèks ofisyèl etid la (Anglè)
Ap chèche patisipan pou yon etid? Mete l anwo paj sa a — $99 pou 30 jou →
A Phase 3 Study of INCA033989 Versus Best Available Therapy in Participants With Essential Thrombocythemia
Ap rekriteFaz 3
- Massachusetts General Hospital, Boston
- Beth Israel Deaconess Medical Center (Bidmc), Boston
Study of INCA036978 in Participants With Myeloproliferative Neoplasms
Ap rekriteFaz 1
- Massachusetts General Hospital, Boston
A Study to Evaluate INCA033989 Administered as a Monotherapy or in Combination With Ruxolitinib in Participants With Myeloproliferative Neoplasms
Ap rekriteFaz 1
- Dana Farber Cancer Institute, Boston
Ruxolitinib in Thrombocythemia and Polycythemia Vera
Ap rekriteFaz 2
- Massachusetts General Hospital, Boston
- Beth-Israel Deaconess Medical Center, Boston
- Dana Farber Cancer Institute, Boston
Etid Trombositemi Esansyèl nan lòt vil
- New York City, NY7 etid
- Durham, NC6 etid
- Chicago, IL4 etid
- Salt Lake City, UT4 etid
- Nashville, TN4 etid
- Baltimore, MD4 etid
- Miami, FL4 etid
- Mountain View, CA4 etid
- Houston, TX3 etid
- Cleveland, OH3 etid
- Irvine, CA3 etid
- Columbus, OH3 etid
Lòt etid nan Boston
- Kansè nan tete111 etid
- Kansè Poumon ki pa ti selil90 etid
- Kansè (tout kalite)86 etid
- Kansè kolorektal63 etid
- Kansè Metastatik63 etid
- Kansè poumon62 etid
- Kansè ovè61 etid
- Kansè pwostat59 etid
- Depresyon52 etid
- Kansè Endomèt50 etid
- Ensifizyans kadyak44 etid
- Leksemi mieloïd egi44 etid
Sous ClinicalTrials.gov, done yo ranmase Oct 5, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.